| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.4 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |